398
Participants
Start Date
May 31, 2012
Primary Completion Date
September 30, 2013
Study Completion Date
December 31, 2013
Asunaprevir
Daclatasvir
Peg-interferon Alfa-2a
Ribavirin
Local Institution, Chiayi City
Local Institution, Kaohsiung City
Local Institution, Lausanne
Local Institution, Prov. Buenos Aires
Local Institution, Hvidovre
Local Institution, Bern
Local Institution, Odense
Local Institution, Mar del Plata
Local Institution, Aalborg
North Shore University Hospital, Manhasset
Local Institution, Taipei
Local Institution, Berlin
University Of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia
Local Institution, Milan
Local Institution, Hamburg
Mcguire Dvamc, Richmond
Local Institution, Brescia
Local Institution, Madrid
Local Institution, Alcorcón
Mayo Clinic, Jacksonville
University Of Miami Schiff Center For Liver Diseases, Miami
Local Institution, Pessac
Local Institution, Montpellier
Alabama Liver & Digestive Specialists (Alds), Montgomery
Gastro One, Germantown
Local Institution, Düsseldorf
Local Institution, Taichung
Local Institution, Seville
University Of Cincinnati, Cincinnati
Dean Clinic, Madison
Local Institution, Cisanello (pisa)
Local Institution, Frankfurt
Local Institution, Heidelberg
Local Institution, Tübingen
Options Health Research, Llc, Tulsa
Local Institution, Paris
Local Institution, Paris
Baylor College Of Medicine, Houston
Texas Liver Institute, San Antonio
Local Institution, Freiburg im Breisgau
University Of Colorado Denver And Hospital, Aurora
South Denver Gastroenterology, Pc, Englewood
Scpmg/ Kaiser Permanente Los Angeles Medical Center, Los Angeles
Local Institution, Palermo
Scripps Clinic, La Jolla
Local Institution, Créteil
Oregon Health & Science University, Portland
Local Institution, Moscow
Local Institution, Moscow
Local Institution, Saint Petersburg
Local Institution, Stavropol
Local Institution, Tyumen
University Of Chicago Medical Center, Chicago
University Of North Carolina At Chapel Hill School Of Med, Chapel Hill
Local Institution, Ciudad de Buenos Aires
Local Institution, Edmonton
Local Institution, Vancouver
Local Institution, Victoria
Local Institution, Toronto
Local Institution, Montreal
Local Institution, Nice
Local Institution, Mexico City
Local Institution, México
Local Institution, Amsterdam
Local Institution, Rotterdam
Local Institution, Bucheon-si
Local Institution, Busan
Local Institution, Busan
Local Institution, Busan
Local Institution, Daegu
Local Institution, Gyeongsangnam-do
Local Institution, Incheon
Local Institution, Incheon
Local Institution, Seoul
Local Institution, Seoul
Local Institution, Barcelona
Local Institution, Gvteborg
Local Institution, Stockholm
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY